Indian Cough Syrup Deaths
- All
- News
- Videos
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
Inside Indian Syrup-Linked Deaths Trial In Uzbekistan: A Bribery Angle
Distributors of a contaminated Indian cough syrup that killed 65 children in Uzbekistan paid local officials a bribe of $33,000 to skip mandatory testing, Uzbek state prosecutors
-
Gambia Says "Advanced" To Explore Legal Action Over Toxic Indian Cough Syrups
Gambia's government is "far advanced" in exploring avenues for potential legal action against Atlantic Pharmaceuticals and Maiden Pharmaceuticals over toxic cough syrups that were imported from India, it said on Friday.
-
India Eyes New Drugs Law After Deaths Linked To Country-Made Cough Syrups
A new drugs bill will be taken up for consideration next week on rules for importing, manufacturing and selling medicines in India, according to a parliamentary notice on Thursday.
-
"Substandard": WHO Alert On 2 Indian Syrups After Uzbekistan Child Deaths
The World Health Organisation (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan.
-
Uzbekistan Blames India-Made Syrup For Deaths, Centre Responds: 10 Facts
The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.
-
"Blinded In Hate For...": BJP vs Congress Over Syrup Linked Deaths In Uzbekistan
The alleged role of Indian pharma companies in the deaths of children abroad led to a verbal tussle between the BJP and the Congress on Thursday.
-
Uzbekistan Says 18 Deaths Linked To India-Made Syrup, Centre Responds
Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.
-
India Inspects Drug Factories As Gambia Controversy Lingers
The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.
-
WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.
-
"Unimaginable Shame": Narayana Murthy On Deaths Due to Indian Cough Syrup
Infosys founder N R Narayana Murthy on Tuesday said the country faces huge challenges in the field of research in sciences despite the country achieving the feat of producing COVID-19 vaccine and inoculating the people of the country.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
WHO Chief Scientist Says Deaths Due To Indian Cough Syrup In Gambia "Serious Issue"
Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.
-
Info On 'Killer' Cough Syrups "Inadequate": India Committee To WHO
The committee to examine reports linking deaths of 66 children in The Gambia to four made-in-India cough syrups has observed the information shared by the World Health Organization is inadequate to determine aetiology.
-
Gambia Says Surge In Child Deaths Due To Indian Cough Syrup Under Control
Gambia's President Adama Barrow on Friday said a surge in acute kidney injuries likely linked to a paracetamol syrup that killed dozens of children in past months was under control, with only two diagnoses in the last two weeks.
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
Inside Indian Syrup-Linked Deaths Trial In Uzbekistan: A Bribery Angle
Distributors of a contaminated Indian cough syrup that killed 65 children in Uzbekistan paid local officials a bribe of $33,000 to skip mandatory testing, Uzbek state prosecutors
-
Gambia Says "Advanced" To Explore Legal Action Over Toxic Indian Cough Syrups
Gambia's government is "far advanced" in exploring avenues for potential legal action against Atlantic Pharmaceuticals and Maiden Pharmaceuticals over toxic cough syrups that were imported from India, it said on Friday.
-
India Eyes New Drugs Law After Deaths Linked To Country-Made Cough Syrups
A new drugs bill will be taken up for consideration next week on rules for importing, manufacturing and selling medicines in India, according to a parliamentary notice on Thursday.
-
"Substandard": WHO Alert On 2 Indian Syrups After Uzbekistan Child Deaths
The World Health Organisation (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan.
-
Uzbekistan Blames India-Made Syrup For Deaths, Centre Responds: 10 Facts
The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.
-
"Blinded In Hate For...": BJP vs Congress Over Syrup Linked Deaths In Uzbekistan
The alleged role of Indian pharma companies in the deaths of children abroad led to a verbal tussle between the BJP and the Congress on Thursday.
-
Uzbekistan Says 18 Deaths Linked To India-Made Syrup, Centre Responds
Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.
-
India Inspects Drug Factories As Gambia Controversy Lingers
The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.
-
WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.
-
"Unimaginable Shame": Narayana Murthy On Deaths Due to Indian Cough Syrup
Infosys founder N R Narayana Murthy on Tuesday said the country faces huge challenges in the field of research in sciences despite the country achieving the feat of producing COVID-19 vaccine and inoculating the people of the country.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
WHO Chief Scientist Says Deaths Due To Indian Cough Syrup In Gambia "Serious Issue"
Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.
-
Info On 'Killer' Cough Syrups "Inadequate": India Committee To WHO
The committee to examine reports linking deaths of 66 children in The Gambia to four made-in-India cough syrups has observed the information shared by the World Health Organization is inadequate to determine aetiology.
-
Gambia Says Surge In Child Deaths Due To Indian Cough Syrup Under Control
Gambia's President Adama Barrow on Friday said a surge in acute kidney injuries likely linked to a paracetamol syrup that killed dozens of children in past months was under control, with only two diagnoses in the last two weeks.
